Two pemphigoid cases with mucous membrane involvement successfully treated with baricitinib
Abstract Both bullous pemphigoid and mucous membrane pemphigoid are autoimmune bullous diseases that can be challenging to treat in individual cases. Janus kinase inhibitors have shown efficacy in several autoimmune and inflammatory diseases, although these drugs are not yet widely used in autoimmun...
Saved in:
| Main Authors: | Tamás Malkovics, Orsolya N. Horváth, Miklós Sárdy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | JEADV Clinical Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jvc2.511 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bullous pemphigoid and mucous membrane pemphigoid humoral responses differ in reactivity towards BP180 midportion and BP230
by: Feliciana Mariotti, et al.
Published: (2024-11-01) -
Bullous pemphigoid treated with baricitinib as steroid-sparing therapy for a patient with uncontrolled diabetes
by: Ji Won Heo, MD, et al.
Published: (2025-03-01) -
A Narrative Review of Pemphigoid Diseases: Bridging Associations, Comorbidities, and Management
by: Emma L. Myers, et al.
Published: (2025-05-01) -
Seborrheic pemphigoid
by: Marcelina Kądziela, et al.
Published: (2025-02-01) -
Scarring Alopecia in a 66‐Year‐Old Woman
by: Sergio Castillo Pinto, et al.
Published: (2025-06-01)